ArticleBritish journal of clinical pharmacology2026

Population pharmacokinetics and exposure-response modelling of firsekibart (GenSci048) in patients with acute gout flare: Implications for fixed-dose optimization.

Kun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.